Every pharmacy owner knows expired medicines are a problem. What most don't realize is how much those write-offs actually cost — not just in the medicine value itself, but across the entire operation.
The obvious loss: the medicine itself
When a medicine expires unsold, you have paid for it and received nothing back. For a mid-size pharmacy carrying 500–1000 SKUs, even a 2–3% expiry rate translates to significant monthly losses. High-value medicines — branded antibiotics, specialty drugs, certain injectables — are where the losses concentrate.
The hidden loss: the supplier return window
Most distributors and manufacturers in India offer a return window — typically 2 to 3 months before expiry. If you return medicines within that window, you recover a portion of the cost, usually 50–80% credit depending on the supplier relationship. Miss that window by even a few days, and the option closes. The medicine is now entirely your loss. This is where manual tracking consistently fails.
The compliance cost
Expired medicines that reach patients — even accidentally — create serious legal liability. A single adverse event traced back to an expired medicine can result in license suspension, fines, and reputational damage that far exceeds the value of the medicine itself. Prevention is dramatically cheaper than remediation.
The compounding effect of dead inventory
Beyond direct write-offs, expired medicines tie up shelf space and purchasing budget. Dead inventory means you're holding cash in stock you can't sell, while running out of fast-moving medicines that customers actually need. Better expiry tracking directly improves cash flow.
What a small improvement actually looks like
If your pharmacy does ₹5 lakh in monthly medicine purchases and currently writes off 3% to expiry, that's ₹15,000 per month in direct losses — ₹1.8 lakh per year. Recovering even half of that through better near-expiry management and supplier returns covers the cost of any inventory system many times over.
The starting point
You can't manage what you can't see. The first step is knowing, in real time, which medicines are expiring in the next 30, 60, and 90 days across your entire stock. That visibility is what MedExpiry provides — and it's free during beta.